Green tea: A novel functional food for the oral health of older adults

Geriatrics and Gerontology International

Volumn 14, Issue 2, 2014, Pages 238-250

  Gaur, Sumit ^a   Agnihotri, Rupali ^a  

^a MANIPAL COLLEGE OF DENTAL SCIENCES   (India)

Author keywords

Chronic periodontitis; Dental caries; Functional food; Green tea; Oral cancer

Indexed keywords

CATECHIN; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; INDUCIBLE NITRIC OXIDE SYNTHASE; POLYPHENOL; REACTIVE OXYGEN METABOLITE; TEA;

ANTIMICROBIAL ACTIVITY; ARTICLE; CHRONIC DISEASE; CHRONIC PERIODONTITIS; CYTOKINE PRODUCTION; DENTAL CARIES; DENTAL HEALTH; FOOD INTAKE; FUNCTIONAL FOOD; GERIATRICS; HALITOSIS; HUMAN; LIPID PEROXIDATION; MOUTH; MOUTH CANCER; MOUTH CAVITY; MOUTH DISEASE; MOUTH HYGIENE; NUTRITIONAL VALUE; OXIDATIVE STRESS; PERIODONTAL DISEASE; PERIODONTAL POCKET; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVATION; TEA; TOOTH DISEASE; AGED; CAMELLIA SINENSIS; HEALTH; MOUTH NEOPLASMS;

AGED; CAMELLIA SINENSIS; FUNCTIONAL FOOD; HUMANS; MOUTH NEOPLASMS; ORAL HEALTH; TEA;

EID: 84897521273     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/ggi.12194     Document Type: Article

References (115)

1. Hasler CM. The changing face of functional foods. J Am Coll Nutr 2000; 19 (Suppl): 499S-506S.
2. Hasler CM, Brown AC, American Dietetic Association. Position of the American Dietetic Association: functional foods. J Am Diet Assoc 2009; 109: 735-746.
3. Shatenstein B, Payette H, Nadon S, Gray-Donald K, Division on Nutrition and Healthy Aging, Québec Network on Aging Research. An approach for evaluating lifelong intakes of functional foods in elderly people. J Nutr 2003; 133: 2384-2391.
4. Benjamin RM. Oral health: the silent epidemic. Public Health Rep 2010; 125: 158-159.
5. Rajendran M, Priyadharshini V, Arora G. Is immunesenescence a contributing factor for periodontal diseases? J Indian Soc Periodontol 2013; 17: 169-174.
6. Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992; 21: 334-350.
7. Lee KW, Lee HJ, Lee CY. Antioxidant activity of black tea vs. green tea. J Nutr 2002; 132: 785.
8. Chan EWC, Soh EY, Tie PP, Law YP. Antioxidant and antibacterial properties of green, black, and herbal teas of Camellia sinensis. Pharmacognosy Res 2011; 3: 266-272.
9. Phipps RP. The second international scientific symposium on tea and human health. Nutrition 1999; 15: 968-971.
10. Kushiyama M, Shimazaki Y, Murakami M, Yamashita Y. Relationship between intake of green tea and periodontal disease. J Periodontol 2009; 80: 372-377.
11. Koyama Y, Kuriyama S, Aida J etal. Association between green tea consumption and tooth loss: cross-sectional results from the Ohsaki Cohort 2006 Study. Prev Med 2010; 50: 173-179.
12. Ide R, Fujino Y, Hoshiyama Y etal. JACC Study Group. A prospective study of green tea consumption and oral cancer incidence in Japan. Ann Epidemiol 2007; 17: 821-826.
13. Wang X, Lussi A. Introduction: functional foods and oral health. Eur J Nutr 2012; 51 (Suppl 2): S13-S14.
14. Spackman SS, Bauer JG. Periodontal treatment for older adults. In: Newman MG, Takei HH, Klokkevold PR, Carranza FA, eds. Carranza's Clinical Periodontology, 10th edn. New Delhi: Elsevier, 2007; 675-692.
15. Duncan AM, Dunn HA, Vella MN, Stratton LM eds. Functional Foods for Healthy Aging: A Toolkit for Registered Dietitians. [Monograph on the Internet]. Ontario: Department of Human Health and Nutritional Sciences, University of Guelph, 2012; [Cited 20 Aug 2013.] Available from URL: http://www.cfdr.ca/Downloads/Presentations/Functional-Foods-For-Healthy-Aging-TOOLKIT-January.aspx
16. Cabrera C, Artacho R, Giménez R. Beneficial effects of green tea-a review. J Am Coll Nutr 2006; 25: 79-99.
17. Braicu C, Pilecki V, Balacescu O, Irimie A, Neagoe IB. The relationships between biological activities and structure of flavan-3-ols. Int J Mol Sci 2011; 12: 9342-9353.
18. Maroon JC, Bost JW, Maroon A. Natural anti-inflammatory agents for pain relief. Surg Neurol Int [serial on the internet]. 2010 Dec; 1: [about 10 p.]. [Cited 20 Aug 2013.] Available from URL: http://www.surgicalneurologyint.com/temp/SurgNeurolInt1180-837469_231546.pdf
19. Lin YL, Lin JK. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol Pharmacol 1997; 52: 465-472.
20. Yang F, Oz HS, Barve S, de Villiers WJ, McClain CJ, Varilek GW. The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol Pharmacol 2001; 60: 528-533.
21. Vasto S, Candore G, Balistreri CR etal. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 2007; 128: 83-91.
22. Katiyar SK, Raman C. Green tea: a new option for the prevention or control of osteoarthritis. Arthritis Res Ther [serial on the internet]. 2011 August; 13:[about 2p.]. [Cited 23 Aug 2013.] Available from URL: http://arthritis-research.com/content/pdf/ar3428.pdf
23. Cannizzo ES, Clement CC, Sahu R, Follo C, Santambrogio L. Oxidative stress, inflamm-aging and immunosenescence. J Proteomics 2011; 74: 2313-2323.
24. Tipoe GL, Leung TM, Hung MW, Fung ML. Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc Hematol Disord Drug Targets 2007; 7: 135-144.
25. Babu PV, Liu D. Green tea catechins and cardiovascular health: an update. Curr Med Chem 2008; 15: 1840-1850.
26. Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci U S A 2004; 101: 4003-4008.
27. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993; 57: 715S-724S.
28. Tedeschi E, Menegazzi M, Yao Y, Suzuki H, Förstermann U, Kleinert H. Green tea inhibits human inducible nitric-oxide synthase expression by down regulating signal transducer and activator of transcription-1alpha activation. Mol Pharmacol 2004; 65: 111-120.
29. van Acker SA, de Groot MJ, van den Berg DJ etal. A quantum chemical explanation of the antioxidant activity of flavonoids. Chem Res Toxicol 1996; 9: 1305-1312.
30. Morel I, Lescoat G, Cogrel P etal. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem Pharmacol 1993; 45: 13-19.
31. Khan SG, Katiyar SK, Agarwal R, Mukhtar H. Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention. Cancer Res 1992; 52: 4050-4052.
32. Anisimov VN. Biology of aging and cancer. Cancer Control 2007; 14: 23-31.
33. Fujiki H. Two stages of cancer prevention with green tea. J Cancer Res Clin Oncol 1999; 125: 589-597.
34. Imai K, Suga K, Nakachi K. Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med 1997; 26: 769-775.
35. Mukhtar H, Ahmad N. Mechanism of cancer chemopreventive activity of green tea. Proc Soc Exp Biol Med 1999; 220: 234-238.
36. Beltz LA, Bayer DK, Moss AL, Simet IM. Mechanisms of cancer prevention by green and black tea polyphenols. Anticancer Agents Med Chem 2006; 6: 389-406.
37. Proniuk S, Liederer BM, Blanchard J. Preformulation study of epigallocatechin gallate, a promising antioxidant for topical skin cancer prevention. J Pharm Sci 2002; 91: 111-116.
38. Fujimoto N, Sueoka N, Sueoka E etal. Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1. Int J Oncol 2002; 20: 1233-1239.
39. Berger SJ, Gupta S, Belfi CA, Gosky DM, Mukhtar H. Green tea constituent (-)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells. Biochem Biophys Res Commun 2001; 288: 101-105.
40. Takada M, Nakamura Y, Koizumi T etal. Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate. Pancreas 2002; 25: 45-48.
41. Gupta S, Hussain T, Mukhtar H. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 2003; 410: 177-185.
42. Sartippour MR, Shao ZM, Heber D etal. Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J Nutr 2002; 132: 2307-2311.
43. Taylor PW, Hamilton-Miller JM, Stapleton PD. Antimicrobial properties of green tea catechins. Food Sci Technol Bull 2005; 2: 71-81.
44. Yam TS, Hamilton-Miller JM, Shah S. The effect of a component of tea (Camellia sinensis) on methicillin resistance, PBP2 synthesis and beta-lactamase production in Staphylococcus aureus. J Antimicrob Chemother 1998; 42: 211-216.
45. Isogai E, Isogai H, Hirose K, Hayashi S, Oguma K. In vivo synergy between green tea extract and levofloxacin against enterohemorrhagic Escherichia coli O157 infection. Curr Microbiol 2001; 42: 248-251.
46. Zhao WH, Hu ZQ, Hara Y, Shimamura T. Inhibition by epigallocatechin gallate (EGCg) of conjugative R plasmid transfer in Escherichia coli. J Infect Chemother 2001; 7: 195-197.
47. Sudano Roccaro A, Blanco AR, Giuliano F, Rusciano D, Enea V. Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells. Antimicrob Agents Chemother 2004; 48: 1968-1973.
48. Ikigai H, Nakae T, Hara Y, Shimamura T. Bactericidal catechins damage the lipid bilayer. Biochim Biophys Acta 1993; 1147: 132-136.
49. Navarro-Martínez MD, Navarro-Perán E, Cabezas-Herrera J, Ruiz-Gómez J, García-Cánovas F, Rodríguez-López JN. Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2005; 49: 2914-2920.
50. Zhang YM, Rock CO. Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase. J Biol Chem 2004; 279: 30994-31001.
51. Sieradzki K, Tomasz A. Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus. J Bacteriol 2003; 185: 7103-7110.
52. Stapleton PD, Shah S, Ehlert K, Hara Y, Taylor PW. The beta-lactam-resistance modifier (-)-epicatechin gallate alters the architecture of the cell wall of Staphylococcus aureus. Microbiology 2007; 153: 2093-2103.
53. Hashimoto T, Kumazawa S, Nanjo F, Hara Y, Nakayama T. Interaction of tea catechins with lipid bilayers investigated with liposome systems. Biosci Biotechnol Biochem 1999; 63: 2252-2255.
54. Kumazawa S, Kajiya K, Naito A etal. Direct evidence of interaction of a green tea polyphenol, epigallocatechin gallate, with lipid bilayers by solid-state Nuclear Magnetic Resonance. Biosci Biotechnol Biochem 2004; 68: 1743-1747.
55. Kale SS, Yende S. Effects of aging on inflammation and hemostasis through the continuum of critical illness. Aging Dis 2011; 2: 501-511.
56. Tarannum F, Faizuddin M. Effect of gene polymorphisms on periodontal diseases. Indian J Hum Genet 2012; 18: 9-19.
57. Kudva P, Tabasum ST, Shekhawat NK. Effect of green tea catechin, a local drug delivery system as an adjunct to scaling and root planing in chronic periodontitis patients: a clinicomicrobiological study. J Indian Soc Periodontol 2011; 15: 39-45.
58. Hirasawa M, Takada K, Makimura M, Otake S. Improvement of periodontal status by green tea catechin using a local delivery system: a clinical pilot study. J Periodontal Res 2002; 37: 433-438.
59. Okamoto M, Sugimoto A, Leung KP, Nakayama K, Kamaguchi A, Maeda N. Inhibitory effect of green tea catechins on cysteine proteinases in Porphyromonas gingivalis. Oral Microbiol Immunol 2004; 19: 118-120.
60. Okamoto M, Leung KP, Ansai T, Sugimoto A, Maeda N. Inhibitory effects of green tea catechins on protein tyrosine phosphatase in Prevotella intermedia. Oral Microbiol Immunol 2003; 18: 192-195.
61. Sakanaka S, Aizawa M, Kim M, Yamamoto T. Inhibitory effects of green tea polyphenols on growth and cellular adherence of an oral bacterium, Porphyromonas gingivalis. Biosci Biotechnol Biochem 1996; 60: 745-749.
62. Makimura M, Hirasawa M, Kobayashi K etal. Inhibitory effect of tea catechins on collagenase activity. J Periodontol 1993; 64: 630-636.
63. Kirkwood KL, Cirelli JA, Rogers JE, Giannobile WV. Novel host response therapeutic approaches to treat periodontal diseases. Periodontol 2000 2007; 43: 294-315.
64. Syed DN, Afaq F, Kweon MH etal. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells. Oncogene 2007; 26: 673-682.
65. Shen CL, Yeh JK, Samathanam C etal. Green tea polyphenols atteenutae deterioration of bone microarchitecture in female rats with systemic chronic inflammation. Osteoporos Int 2011; 22: 327-337.
66. Ahmed S, Wang N, Lalonde M, Goldberg VM, Haqqi TM. Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta - induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J Pharmacol Exp Ther 2004; 308: 767-773.
67. Nakamura H, Ukai T, Yoshimura A etal. Green tea catechin inhibits lipopolysaccharide-induced bone resorption in vivo. J Periodontal Res 2010; 45: 23-30.
68. Narotzki B, Reznick AZ, Aizenbud D, Levy Y. Green tea: a promising natural product in oral health. Arch Oral Biol 2012; 57: 429-435.
69. Nakagawa T, Yokozawa T. Direct scavenging of nitric oxide and superoxide by green tea. Food Chem Toxicol 2002; 40: 1745-1750.
70. Chung HY, Yokozawa T, Soung DY, Kye IS, No JK, Baek BS. Peroxynitrite-scavenging activity of green tea tannin. J Agric Food Chem 1998; 46: 4484-4486.
71. Desjardins J, Grenier D. Neutralizing effect of green tea epigallocatechin-3-gallate on nicotine-induced toxicity and chemokine (C-C motif) ligand 5 secretion in human oral epithelial cells and fibroblasts. J Investig Clin Dent 2012; 3: 189-197.
72. Kang SW, Park HJ, Ban JY, Chung JH, Chun GS, Cho JO. Effects of nicotine on apoptosis in human gingival fibroblasts. Arch Oral Biol 2011; 56: 1091-1097.
73. Weitberg AB, Corvese D. The effect of epigallocatechin gallate and sarcophytol A on DNA strand breakage induced by tobacco-specific nitrosamines and stimulated human phagocytes. J Exp Clin Cancer Res 1999; 18: 433-437.
74. Beretta G, Furlanetto S, Regazzoni L, Zarrella M, Facino RM. Quenching of alpha, beta-unsaturated aldehydes by green tea polyphenols: HPLC-ESI-MS/MS studies. J Pharm Biomed Anal 2008; 48: 606-611.
75. Xu X, Zhou XD, Wu CD. The tea catechin epigallocatechin gallate suppresses cariogenic virulence factors of Streptococcus mutans. Antimicrob Agents Chemother 2011; 55: 1229-1236.
76. Petersen PE, Yamamoto T. Improving the oral health of older people: the approach of the WHO Global Oral Health Programme. Community Dent Oral Epidemiol 2005; 33: 81-92.
77. Anderson M. Risk assessment and epidemiology of dental caries: review of the literature. Pediatr Dent 2002; 24: 377-385.
78. Fure S. Ten-year incidence of tooth loss and dental caries in elderly Swedish individuals. Caries Res 2003; 37: 462-469.
79. van Loveren C, Broukal Z, Oganessian E. Functional foods/ingredients and dental caries. Eur J Nutr 2012; 51 (Suppl 2): S15-S25.
80. Yu H, Oho T, Xu LX. Effects of several tea components on acid resistance of human tooth enamel. J Dent 1995; 23: 101-105.
81. Wu CD, Wei GX. Tea as a functional food for oral health. Nutrition 2002; 18: 443-444.
82. Otake S, Makimura M, Kuroki T, Nishihara Y, Hirasawa M. Anticaries effects of polyphenolic compounds from Japanese green tea. Caries Res 1991; 25: 438-443.
83. Ooshima T, Minami T, Aono W etal. Oolong tea polyphenols inhibit experimental dental caries in SPF rats infected with mutans streptococci. Caries Res 1993; 27: 124-129.
84. Ooshima T, Minami T, Matsumoto M, Fujiwara T, Sobue S, Hamada S. Comparison of the cariostatic effects between regimens to administer oolong tea polyphenols in SPF rats. Caries Res 1998; 32: 75-80.
85. Lemos JA, Burne RA. A model of efficiency: stress tolerance by Streptococcus mutans. Microbiology 2008; 154: 3247-3255.
86. Kawamura J, Takeo T. Antibacterial activity of tea catechin to Streptococcus mutans. J Jpn Soc Food Sci Technol 1989; 36: 463-467.
87. Hirasawa M, Takada K, Otake S. Inhibition of acid production in dental plaque bacteria by green tea catechins. Caries Res 2006; 40: 265-270.
88. Southward K. The systemic theory of dental caries. Gen Dent 2011; 59: 367-373.
89. Kato MT, Leite AL, Hannas AR, Buzalaf MA. Gels containing MMP inhibitors prevent dental erosion in situ. J Dent Res 2010; 89: 468-472.
90. Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 2006; 66: 2500-2505.
91. Williams HK. Molecular pathogenesis of oral squamous carcinoma. Mol Pathol 2000; 53: 165-172.
92. Rajamanickam S, Agarwal R. Natural products and colon cancer: current status and future prospects. Drug Dev Res 2008; 69: 460-471.
93. Tsao AS, Liu D, Martin J etal. Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res (Phila) 2009; 2: 931-941.
94. Yoon AJ, Shen J, Santella RM etal. Topical Application of Green Tea Polyphenol (-)-Epigallocatechin-3-gallate (EGCG) for prevention of recurrent oral neoplastic lesions. J Orofac Sci 2012; 4: 43-50.
95. Lee MJ, Lambert JD, Prabhu S etal. Delivery of tea polyphenols to the oral cavity by green tea leaves and black tea extract. Cancer Epidemiol Biomarkers Prev 2004; 13: 132-137.
96. Masuda M, Suzui M, Lim JT, Weinstein IB. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin Cancer Res 2003; 9: 3486-3491.
97. Kato K, Long NK, Makita H etal. Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br J Cancer 2008; 99: 647-654.
98. Ho YC, Yang SF, Peng CY, Chou MY, Chang YC. Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the production of matrix metalloproteinases and urokinase-plasminogen activator. J Oral Pathol Med 2007; 36: 588-593.
99. Lee UL, Choi SW. The chemopreventive properties and therapeutic modulation of green tea polyphenols in oral squamous cell carcinoma. ISRN Oncol [serial on the internet]. 2011. March; 2011: [about .7p.]. [Cited 23 Aug 2013.] Available from URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197077/pdf/ONCOLOGY2011-403707.pdf
100. Khafif A, Schantz SP, Chou TC, Edelstein D, Sacks PG. Quantification of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Cacinogenesis 1998; 19: 419-424.
101. Mohan KV, Gunasekaran P, Varalakshmi E, Hara Y, Nagini S. In vitro evaluation of the anticancer effect of lactoferrin and tea polyphenol combination on oral carcinoma cells. Cell Biol Int 2007; 31: 599-608.
102. Amin AR, Khuri FR, Chen ZG, Shin DM. Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB. Cancer Prev Res (Phila) 2009; 2: 538-545.
103. Chandra Mohan KV, Hara Y, Abraham SK, Nagini S. Comparative evaluation of the chemopreventive efficacy of green and black tea polyphenols in the hamster buccal pouch carcinogenesis model. Clin Biochem 2005; 38: 879-886.
104. Srinivasan P, Suchalatha S, Babu PV etal. Chemopreventive and therapeutic modulation of green tea polyphenols on drug metabolizing enzymes in 4-Nitroquinoline 1-oxide induced oral cancer. Chem Biol Interact 2008; 172: 224-234.
105. Siddiqui IA, Mukhtar H. Nanochemoprevention by bioactive food components: a perspective. Pharm Res 2010; 27: 1054-1060.
106. Mirkarimi M, Toomarian L. Effect of green tea extract on the treatment of dentin erosion: an in vitro study. J Dent (Tehran) 2012; 9: 224-228.
107. Lussi A. Erosive tooth wear - a multifactorial condition of growing concern and increasing knowledge. Monogr Oral Sci 2006; 20: 1-8.
108. Tjäderhane L, Larjava H, Sorsa T, Uitto VJ, Larmas M, Salo T. The activation and function of host matrix metalloproteinases in dentin matrix breakdown in caries lesions. J Dent Res 1998; 77: 1622-1629.
109. Moon PC, Weaver J, Brooks CN. Review of matrix metalloproteinases effect on the hybrid dentin bond layer stability and chlorhexidine clinical use to prevent bond failure. Open Dent J 2010; 4: 147-152.
110. Ostrowska J, Skrzydlewska E. The comparison of effect of catechins and green tea extract on oxidative modification of LDL in vitro. Adv Med Sci 2006; 51: 298-303.
111. Jiao HL, Ye P, Zhao BL. Protective effects of green tea polyphenols on human Hep G2 cells against oxidative damage of fenofibrate. Free Radic Biol Med 2003; 35: 1121-1128.
112. Rassameemasmaung S, Phusudsawang P, Sangalungkarn V. Effect of Green Tea Mouthwash on Oral Malodor. ISRN Prev Med [serial on the internet] 2013: [about 6 p.]. [Cited 23 Aug 2013.] Available from URL: http://www.hindawi.com/isrn/pm/2013/975148/cta/
113. Zeng QC, Wu AZ, Pika J. The effect of green tea extract on the removal of sulfur-containing oral malodor volatiles in vitro and its potential application in chewing gum. J Breath Res [serial on the internet] 2010 August; 4. [Cited 23 Aug 2013.] Available from URL: http://iopscience.iop.org/1752-7163/4/3/036005
114. Farina VH, Lima AP, Balducci I, Brandão AA. Effects of the medicinal plants curcuma Zedoria and Camellia sinensis halitosis control. Braz Oral Res 2012; 26: 523-529.
115. Lodhia P, Yaegaki K, Khakbaznejad A etal. effect of green tea on volatile sulphur compounds in mouth air. J Nutr Sci Vitaminol (Tokyo) 2008; 54: 89-94.